Metaphedrine
Tools
Actions
General
Print/export
In other projects
Appearance
From Wikipedia, the free encyclopedia
Designer drug
Pharmaceutical compound
Legal status | |
---|---|
Legal status | |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C11H17N |
Molar mass | 163.264 g·mol−1 |
3D model (JSmol) | |
| |
|
3-Methylmethamphetamine (3-MMA) or Metaphedrine is an amphetamine derivative which has been sold as a designer drug, first being reported in Sweden in 2021.[1]
See also
[edit]- 3-Chloromethamphetamine
- 3-Methoxymethamphetamine
- 3-Methylamphetamine
- 3-Methylmethcathinone
- 3-Me-PVP
- 4-Methylmethamphetamine
- Fenfluramine
- 3,4-Dimethylamphetamine
References
[edit]- ^ European Monitoring Centre for Drugs and Drug Addiction. (June 2022). New psychoactive substances: 25 years of early warning and response in Europe. An update from the EU Early Warning System (PDF). European Monitoring Centre for Drugs and Drug Addiction. doi:10.2810/882318 (inactive 2024-11-02). ISBN 978-92-9497-737-3.
{{cite book}}
: CS1 maint: DOI inactive as of November 2024 (link)
This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it. |
Hidden categories:
- CS1 maint: DOI inactive as of November 2024
- Articles with short description
- Short description is different from Wikidata
- Drugs with non-standard legal status
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without UNII source
- Drugs missing an ATC code
- Articles containing unverified chemical infoboxes
- All stub articles